HIV-1-associated encephalopathy and myelopathy;HIV-1-assoziierte Enzephalopathie und Myelopathie

Nervenarzt

Volumn 71, Issue 8, 2000, Pages 677-684

  Eggers, Christian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Dementia; Encephalopathy; HIV 1 Infection

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; BRAIN DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOTOR DYSFUNCTION; PATHOGENESIS; SPINAL CORD DISEASE; VIRUS REPLICATION;

AIDS DEMENTIA COMPLEX; ANTIVIRAL AGENTS; BLOOD-BRAIN BARRIER; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; NEUROPSYCHOLOGICAL TESTS; SPINAL CORD DISEASES; VIRAL LOAD;

EID: 0033883904     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050646     Document Type: Article

References (59)

1. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
2. Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit
3. Motor analysis predicts progression in HIV-associated brain disease
4. Electrophysiological motor testing, MRI findings and clinical course in AIDS patients with dementia
5. Magnetic stimulation of motor cortex in relation to fastest voluntary motor activity in neurologically asymptomatic HIV-positive patients
6. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
7. Neuropathology of human immunodeficiency virus infection
8. Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis
9. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: An autopsybased case-control study
10. A pilot study of L-methionine for the treatment of AIDS-associated myelopathy
11. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
12. Rapid clearance of human immunodeficiency virus from ventricular cerebrospinal fluid during antiretroviral treatment
13. HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in the cerebrospinal fluid
14. Cerebrospinal fluid human immunodeficiency virus 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immundodeficiency syndrome
15. Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection
16. Antiretroviral drugs and the central nervous system [editorial]
17. Value of electroencephalography in AIDS
18. Fur die Deutsche Neuro-AIDS Arbeitsgemeinschaft (1999) Antiretroviral therapy (ART) from a neurological point of view. German Neuro-AIDS study group (DNAA)
19. Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia
20. Impact of antiretroviral treatment on AIDS dementia: A longitudinal prospective event-related potential study
21. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in HIV-associated dementia
22. The Prometheus study: Double protease inhibitor treatment only is unable to suppress detectable viral load in the CSF
23. Neuropathology of early HIV-1 infection
24. New-onset psychosis in HIV-infected patients
25. Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (slCAM-1) in patients with HIV-1 associated neurological diseases
26. Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force
27. Loss of neurons in the frontal cortex in AIDS brains
28. HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system
29. Dementia associated with the acquired immunedeficieny syndrome
30. Acute diffuse leukoencephalitis in HIV-1 infection
31. Veranderungen am Ruckenmark: Vakuolare Aids-Myelopathie und andere Myelopathien bei HIV-lnfektion
32. Increased neuropeptide Y-like immuno-reactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: Relationship to HIV encephalopathy
33. HIV-1 assoziierte autonome Dysfunktion (HIVAD)
34. Dementia in AIDS-patients: Incidence and risk factors
35. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
36. Metabolic characterization of AIDS dementia complex by spectroscopic imaging
37. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis
38. A phase I/II trial of nimodipine for HIV-related neurologic complications
39. The AIDS dementia complex: I. Clinical features
40. Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions
41. Zidovudine for HIV-related myelopathy [letter]
42. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome
43. Demented and Nondemented Patients with AIDS Differ in Brain-Derived Human Immuno-deficiency Virus Type 1 Envelope Sequences
44. HIV-dementia scale: A rapid screening test
45. The AIDS dementia complex
46. The Dana Consortium on therapy of H.I.V. dementia. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in HIV-associated cognitive impairment
47. Chemokines and receptors in HIV encephalitis
48. Reduced cerebral blood flow in early stages of HIV infection
49. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex
50. Neurological complications of acquired immue deficiency syndrome: Analysis of 50 patients
51. Human immunodeficiency virus type-1 protein Nef induces blood-brain barrier disruption in the rat: Role of matrix metalloproteinase-9
52. Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients
53. Distinct populations of HIV type 1 in blood and CSF
54. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry
55. Evidence for different immune responses to HIV in CSF and serum?
56. Neocortical damage during HIV infection
57. Distribution of brain HIV load in AIDS
58. In vivo compartmentalization of HIV: Evidence from the examination of pol sequences from autopy tissues
59. Seizures in human immunodeficiency virus infection